'Clinical endpoint' presentation slideshows

Peter Gilbert Vaccine Infectious Disease Institute

Evaluating an Immunological Surrogate of Protection. Peter Gilbert Vaccine Infectious Disease Institute Fred Hutchinson Cancer Research Center and University of Washington December 14, 2009. Prototype Preventive Vaccine Efficacy Trial. Primary Objective

788 views • 62 slides

Clinical Trials

Clinical Trials. Penny Hogarth, MD OHSU Department of Neurology April 6th, 2007. What is a clinical trial?. A clinical trial is a tool for testing a drug, device or technique. Why do a clinical trial?. To answer a clinical problem To gain new knowledge about a new or established treatment

861 views • 51 slides

ISCB Vaccines Sub-Committee Web Seminar Series November 7 , 2012

Assessing Immune Correlates of Protection Via Estimation of the Vaccine Efficacy Curve Peter Gilbert Fred Hutchinson Cancer Research Center and University of Washington, Department of Biostatistics. ISCB Vaccines Sub-Committee Web Seminar Series November 7 , 2012. Outline .

749 views • 50 slides

NOTE FOR HEALTHCARE PROFESSIONAL

NOTE FOR HEALTHCARE PROFESSIONAL. This presentation has been provided to you upon request. If presenting this to other healthcare professionals, GSK advises that you use the presentation in full to ensure a fair balance of information, both efficacy and safety.

562 views • 44 slides

Evolving Science in Bioavailability and Bioequivalence

Evolving Science in Bioavailability and Bioequivalence. Jim Wei, MD, PhD x.wei@medpace.com. ACPU, Cincinnati, OH, October 18-20, 2010. Agenda. Bioavailability/Bioequivalence Highly variable drugs (HVD) Study Design of Bioequivalence Average BE Replicate BE - Full replicate

628 views • 22 slides

Longitudinal Analysis Beyond effect size

Longitudinal Analysis Beyond effect size. Cheikh Diack & Nicolas Frey M&S - Translational Research Sciences EFSPI 13 th September 2012. Only size (of effect) matters! The benefit of a treatment is given by the size of its impact on clinical endpoints. baseline. EFFECT SIZE.

313 views • 21 slides

Challenges from Drug Eluting Stent (DES) Studies - Future DES Study Design

299 views • 16 slides

Challenges from Drug Eluting Stent (DES) Studies - Future DES Study Design

281 views • 16 slides

Licensure of Pandemic Influenza Vaccines: Demonstration of Effectiveness

347 views • 10 slides

Domestic Data

143 views • 6 slides